FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890118318> ?p ?o ?g. }

• W2890118318 endingPage "1477" @default.
• W2890118318 startingPage "1477" @default.
• W2890118318 abstract "Ischemic stroke with large-vessel occlusion can be treated with alteplase and/or endovascular therapy; however, the administration of each treatment is time sensitive.To identify the optimal triage and transport strategy: direct to the endovascular center (mothership) or immediate alteplase treatment followed by transfer to the endovascular center (drip and ship), for all patients with suspected large-vessel occlusion stroke.This was a theoretical, conditional probability modeling study. Existing data from clinical trials of stroke treatment were used for model generation. The study was conducted from February 1, 2017, to March 1, 2018.The time-dependent efficacy of alteplase and endovascular therapy and the accuracy of large-vessel occlusion screening tools were modeled to estimate the probability of positive outcome (modified Rankin Scale score, 0-1 at 90 days) for both the drip-and-ship and mothership transport strategies. Based from onset to treatment, the strategy that estimates the greatest probability of excellent outcome is determined in several different scenarios.The patient's travel time from both thrombolysis and endovascular therapy centers, speed of treatment, and positive predictive value of the screening tool affect whether the drip-and-ship or mothership strategy estimates best outcomes. With optimal treatment times (door-to-needle time: 30 minutes; door-in-door-out time: 50 minutes; door-to-groin-puncture time: 60 minutes [mothership], 30 minutes [drip and ship]), both options estimate similar outcomes when the centers are 60 minutes or less apart. However, with increasing travel time between the 2 centers (90 or 120 minutes), drip and ship is favored if the patient would have to travel past the thrombolysis center to reach the endovascular therapy center or if the patient would arrive outside the alteplase treatment time window in the mothership scenario. Holding other variables constant, if treatment times are slow at the thrombolysis center (door-to-needle time: 60 minutes; door-in-door-out time: 120 minutes), the area where mothership estimates the best outcomes expands, especially when the 2 centers are close together (60 minutes apart or less). The area where mothership estimates the best outcome also expands as the positive predictive value of the screening tool increases.This study suggests that decision making for prehospital transport can be modeled using existing clinical trial data and that these models can be dynamically adapted to changing realities. Based on current median treatment times to realize the full benefit of endovascular therapy on a population level, the study findings suggest that delivery of the treatment should be regionally centralized. The study modeling suggests that transport decision making is context specific and the radius of superiority of the transport strategy changes based on treatment times at both centers, transport times, and the triaging tool used." @default.
• W2890118318 created "2018-09-27" @default.
• W2890118318 creator A5005032296 @default.
• W2890118318 creator A5020373936 @default.
• W2890118318 creator A5020883910 @default.
• W2890118318 creator A5056711512 @default.
• W2890118318 creator A5065982019 @default.
• W2890118318 creator A5080100010 @default.
• W2890118318 creator A5080929249 @default.
• W2890118318 creator A5081925377 @default.
• W2890118318 creator A5084100416 @default.
• W2890118318 date "2018-12-01" @default.
• W2890118318 modified "2023-10-16" @default.
• W2890118318 title "Modeling Stroke Patient Transport for All Patients With Suspected Large-Vessel Occlusion" @default.
• W2890118318 cites W1549936717 @default.
• W2890118318 cites W1971631039 @default.
• W2890118318 cites W1992520798 @default.
• W2890118318 cites W2003806741 @default.
• W2890118318 cites W2009849279 @default.
• W2890118318 cites W2069849407 @default.
• W2890118318 cites W2074954553 @default.
• W2890118318 cites W2104941082 @default.
• W2890118318 cites W2112161237 @default.
• W2890118318 cites W2121300729 @default.
• W2890118318 cites W2142640478 @default.
• W2890118318 cites W2143566210 @default.
• W2890118318 cites W2165568749 @default.
• W2890118318 cites W2168897254 @default.
• W2890118318 cites W2171672167 @default.
• W2890118318 cites W2277258071 @default.
• W2890118318 cites W2282463681 @default.
• W2890118318 cites W2292786043 @default.
• W2890118318 cites W2330133051 @default.
• W2890118318 cites W2340148706 @default.
• W2890118318 cites W2418668754 @default.
• W2890118318 cites W2526978419 @default.
• W2890118318 cites W2528859445 @default.
• W2890118318 cites W2557937620 @default.
• W2890118318 cites W2572047800 @default.
• W2890118318 cites W2588575044 @default.
• W2890118318 cites W2589902638 @default.
• W2890118318 cites W2599915477 @default.
• W2890118318 cites W2757806859 @default.
• W2890118318 cites W2767776410 @default.
• W2890118318 cites W4247502312 @default.
• W2890118318 cites W2606073942 @default.
• W2890118318 doi "https://doi.org/10.1001/jamaneurol.2018.2424" @default.
• W2890118318 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6583214" @default.
• W2890118318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30193366" @default.
• W2890118318 hasPublicationYear "2018" @default.
• W2890118318 type Work @default.
• W2890118318 sameAs 2890118318 @default.
• W2890118318 citedByCount "113" @default.
• W2890118318 countsByYear W28901183182018 @default.
• W2890118318 countsByYear W28901183182019 @default.
• W2890118318 countsByYear W28901183182020 @default.
• W2890118318 countsByYear W28901183182021 @default.
• W2890118318 countsByYear W28901183182022 @default.
• W2890118318 countsByYear W28901183182023 @default.
• W2890118318 crossrefType "journal-article" @default.
• W2890118318 hasAuthorship W2890118318A5005032296 @default.
• W2890118318 hasAuthorship W2890118318A5020373936 @default.
• W2890118318 hasAuthorship W2890118318A5020883910 @default.
• W2890118318 hasAuthorship W2890118318A5056711512 @default.
• W2890118318 hasAuthorship W2890118318A5065982019 @default.
• W2890118318 hasAuthorship W2890118318A5080100010 @default.
• W2890118318 hasAuthorship W2890118318A5080929249 @default.
• W2890118318 hasAuthorship W2890118318A5081925377 @default.
• W2890118318 hasAuthorship W2890118318A5084100416 @default.
• W2890118318 hasBestOaLocation W28901183181 @default.
• W2890118318 hasConcept C126322002 @default.
• W2890118318 hasConcept C127413603 @default.
• W2890118318 hasConcept C141071460 @default.
• W2890118318 hasConcept C194828623 @default.
• W2890118318 hasConcept C2776098176 @default.
• W2890118318 hasConcept C2776268601 @default.
• W2890118318 hasConcept C2777120189 @default.
• W2890118318 hasConcept C2779581417 @default.
• W2890118318 hasConcept C2779967601 @default.
• W2890118318 hasConcept C2780645631 @default.
• W2890118318 hasConcept C3018386432 @default.
• W2890118318 hasConcept C500558357 @default.
• W2890118318 hasConcept C71924100 @default.
• W2890118318 hasConcept C78519656 @default.
• W2890118318 hasConceptScore W2890118318C126322002 @default.
• W2890118318 hasConceptScore W2890118318C127413603 @default.
• W2890118318 hasConceptScore W2890118318C141071460 @default.
• W2890118318 hasConceptScore W2890118318C194828623 @default.
• W2890118318 hasConceptScore W2890118318C2776098176 @default.
• W2890118318 hasConceptScore W2890118318C2776268601 @default.
• W2890118318 hasConceptScore W2890118318C2777120189 @default.
• W2890118318 hasConceptScore W2890118318C2779581417 @default.
• W2890118318 hasConceptScore W2890118318C2779967601 @default.
• W2890118318 hasConceptScore W2890118318C2780645631 @default.
• W2890118318 hasConceptScore W2890118318C3018386432 @default.
• W2890118318 hasConceptScore W2890118318C500558357 @default.
• W2890118318 hasConceptScore W2890118318C71924100 @default.
• W2890118318 hasConceptScore W2890118318C78519656 @default.

• next